Home » Newsletters » BioWorld Science

BioWorld Science

May 10, 2004

View Archived Issues

Methylphenidate enhances the beneficial effects of levodopa in Parkinson's disease

Adiponectin reduces body weight in mice by increasing metabolic rate without reducing food intake

Intravitreal pegaptanib reported safe and effective in ocular neovascularization disorders

Ono scientists describe new chemokine CCR5 antagonists and their therapeutic use

New immunosuppressant agents covered by Kyorin patent

Dual D2/5-HT2A antagonists for use in schizophrenia claimed by Pfizer

Schering-Plough and Pharmacopeia present novel CDK inhibitors

New inhibitors of cytokine release under study at Procter & Gamble

Salsalate shows promise as a novel drug for type 2 diabetes

Vitrase approved by FDA as spreading agent; phase III results in vitreous hemorrhage also presented

Novel cannabinoid CB1 ligands prepared and tested at Solvay

Inhaled insulin reported more effective than other therapies for type 2 diabetes

Two series of chemokine CCR5 antagonists and their use in HIV infection

Good safety profile of mycophenolate mofetil in multiple sclerosis

Newron and Zambon on pain treatment development

Phase II trial under way for TNX-355 for HIV

Aurograb enters phase III

Regulatory clearances for Cerepro study

Tectin enters pivotal trial in cancer-related pain

Samaritan advances HIV pipeline

PD-6735 successfully completes phase I trial, enters phase II

Anthim selected for testing by CDC

Imvamune IND receives approval

BioLineRx licenses neurological platform from Tel Aviv, Bar Ilan Universities

Pivotal BioSciences and ProteomTech collaborate on development of PB1

Completion of ReceptoPharm's HIV in vitro studies

Positive opinion for Humira label extension in E.U.

Ilex Oncology focuses on key compounds during first quarter

Celgene increases R&D investment in Q1 2004

Merck & Co. highlights first quarter developments

Further data on use of darifenacin for treatment of overactive bladder

AUA news: First clinical results with stem cell therapy in urinary incontinence presented

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Brenig Therapeutics discovers new LRRK2 inhibitors
BioWorld Science
Brenig Therapeutics Inc. has described leucine-rich repeat kinase 2 (LRRK2; dardarin) and (LRRK2; dardarin) (G2019S mutant) inhibitors reported to be useful for...